OKLO is trading near where its own founders sold, with short sellers holding firm and a fresh earnings date on the calendar.
The most striking feature of the current setup is insider behaviour. On May 1, co-founders and CEO Jacob DeWitte and COO Caroline Cochran, along with CFO Richard Bealmear, sold a combined $14 million worth of stock at prices between $69 and $71. The stock has since retreated to $65.88, meaning those sales were near the top of the post-earnings range. The Chief Legal Officer added a smaller sale of around $612,000 on May 20. Net of an equity award, the 90-day insider flow is still a meaningful net sell. That kind of cluster across the entire founding team warrants attention, particularly with the next earnings event pencilled in for June 3.
Short interest has drifted modestly higher since the last note — from 18.6% to 18.7% of the free float — so the picture described on May 20 is essentially unchanged. The more notable move is in availability, which has tightened again to roughly 12% after briefly loosening to 25-27% in mid-May. That is still well above the 52-week low of around 4.3%, so the lending pool has room to tighten further. Cost to borrow remains conspicuously cheap at just over 1% — implying new short positions are being added without friction despite the shrinking pool. The ORTEX short score holds at 69.2, ranking in the third percentile of the universe: persistently bearish positioning by any measure.
Options are telling a meaningfully different story. The put/call ratio has eased to 0.70 — roughly in line with its 20-day average and well below the 52-week high of 1.15. Call open interest continues to dominate, suggesting a cohort of investors is positioning for upside even as the short book rebuilds. That divergence — more calls, more shorts simultaneously — reflects genuine disagreement about the stock's direction heading into the June print.
The Street is broadly constructive but far from unified. Ten analysts carry buy-equivalent ratings, with a mean price target around $89 — a 35% premium to the current price. JP Morgan initiated at Neutral this month with an $83 target. Citigroup raised its target from $73.50 to $76 while keeping a Neutral rating. Wedbush and Cantor Fitzgerald reiterated their bullish stances at $110 and $122 respectively. Wolfe Research initiated at Peer Perform last week with no target. The picture is a stock where the bulls are loud but the neutral camp is growing. The bear case centres on fuel supply risk, the ATM offering pointing to ongoing capital needs, and the gap between contracted interest and commercialised megawatts.
The prior earnings print on May 12 delivered a 10.8% single-day drop and a 28.5% five-day decline — the clearest data point in the snapshot for how the market has treated Oklo results. The stock has recovered roughly a third of that five-day loss since. With founders having sold near the highs of that recovery, short interest rebuilt, and availability tightening again, the June 3 print is shaping up as the next real test of whether the bear thesis has overextended or the insider sales were well-timed.
See the live data behind this article on ORTEX.
Open OKLO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
